Feasibility, Efficacy and Safety of IBS ® for Implantaiton in the PDA in Duct-dependent Cyanotic CHD

Clinical trial NCT04291222 · UNKNOWN

Trial details

NCT number: NCT04291222
Sponsor: Lifetech Scientific (Shenzhen) Co., Ltd.
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Patent Ductus Arteriosus Duct-dependent Cyanotic Congenital Heart Disease

Start date: 2018-12-11
Primary completion: 2020-08-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.